;

Valuation for Armata Pharmaceuticals (id:219 ARMP)


Financial Strength

NameCurrentVs IndustryVs History
Trailing P/E -1.02
Forward P/E -1.26
Price to sales 19.26
Price to book -1.38
Enterprise to revenue 58.27
Enterprise to ebitda -5.30

CleverShares.com|
2024 ©

1.0.9119.29486